Showing 1 - 6 results of 6 for search 'Kyu-Pyo Kim', query time: 0.03s Refine Results
  1. 1
    Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysis

    Comparison of surgical outcomes for hip fracture between older patients with and without cancer: a propensity score matching analysis by Chul-Ho Kim, Kyu-pyo Kim, Ji Wan Kim

    Published 2024-03-01
    Get full text
    Article
  2. 2
    631 Pharmacokinetics and pharmacodynamics study of TU2218, TGFβRI and VEGFR2 dual inhibitor in patients with advanced solid tumors

    631 Pharmacokinetics and pharmacodynamics study of TU2218, TGFβRI and VEGFR2 dual inhibitor in patients with advanced solid tumors by Do-Youn Oh, Anthony W Tolcher, Kyu Pyo Kim, Hyesung Shin, Huntaek Kim, Soo Jin Kim, Eunsun Lee

    Published 2023-11-01
    Article
  3. 3
    Serum 25‐Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial

    Serum 25‐Hydroxyvitamin D Levels and Survival Outcomes in Advanced Biliary Tract Cancer: Results From the NIFTY Trial by So Heun Lee, Jaekyung Cheon, Ilhwan Kim, Kyu‐pyo Kim, Baek‐Yeol Ryoo, Jae Ho Jeong, Myoung Joo Kang, Byung Woog Kang, Hyewon Ryu, Ji Sung Lee, Changhoon Yoo

    Published 2025-01-01
    Get full text
    Article
  4. 4
    siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

    siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model by Jae Yun Jung, Hyun Jin Ryu, Seung-Hwan Lee, Dong-Young Kim, Myung Ji Kim, Eun Ji Lee, Yeon-Mi Ryu, Sang-Yeob Kim, Kyu-Pyo Kim, Eun Young Choi, Hyung Jun Ahn, Suhwan Chang

    Published 2021-10-01
    Get full text
    Article
  5. 5
    614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study

    614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study by Bhumsuk Keam, Chan-Young Ock, Do-Youn Oh, Seung-Tae Kim, Keun-Wook Lee, Sun Young Rha, Changhoon Yoo, John Park, Min Hwan Kim, Sehyun Kim, Dhanusha Sabanathan, Joon Oh Park, Napa Parinyanitikul, Kyu Pyo Kim, Jaebong Yoon, Hyelim Lim, Sangheon Lee, Wooick Jang

    Published 2023-11-01
    Article
  6. 6
    Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study

    Prognostic Efficacy of the Albumin-Bilirubin Score and Treatment Outcomes in Hepatocellular Carcinoma: A Large-Scale, Multi-Center Real-World Database Study by Kyu-Pyo Kim, Kang Mo Kim, Baek-Yeol Ryoo, Won-Mook Choi, Won Chul Cha, Mira Kang, Dong Hyun Sinn, Myung Ji Goh, Do Young Kim, Min Ji Lee, Subin Lim, DongKyu Kim, Kyoungdae Baek, Joohyun Kim, Eui Jun Choi, Doik Lee, Jung-Ae Kim, Ki-Hun Kim

    Published 2024-06-01
    Get full text
    Article

Search Tools: